<SUBMISSION>
<ACCESSION-NUMBER>0001144204-05-010330
<TYPE>6-K
<PUBLIC-DOCUMENT-COUNT>3
<PERIOD>20050404
<FILING-DATE>20050404
<DATE-OF-FILING-DATE-CHANGE>20050404
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>pSivida LTD
<CIK>0001314102
<ASSIGNED-SIC>3826
<IRS-NUMBER>000000000
<STATE-OF-INCORPORATION>C3
<FISCAL-YEAR-END>0630
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>6-K
<ACT>34
<FILE-NUMBER>000-51122
<FILM-NUMBER>05727596
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>LEVEL 12 BGC CENTRE
<STREET2>28 THE ESPLANADE
<CITY>PERTH
<STATE>C3
<ZIP>6000
<PHONE>61 8 9226 5099
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>LEVEL 12 BGC CENTRE
<STREET2>28 THE ESPLANADE
<CITY>PERTH
<STATE>C3
<ZIP>6000
</MAIL-ADDRESS>
</FILER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>v015750_6k.htm
<TEXT>
<HTML><HEAD>
<TITLE>
</TITLE>
</HEAD><BODY id=38 bgColor=#ffffff>
<DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=center><FONT
style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><STRONG>SECURITIES
AND EXCHANGE COMMISSION</STRONG></FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=center><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>Washington,
D.C. 20549</STRONG></FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=center><FONT
style="DISPLAY: inline; FONT-SIZE: 18pt; FONT-FAMILY: Times New Roman"><STRONG>FORM
6-K</STRONG></FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=center><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">REPORT OF
FOREIGN ISSUER</FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=center><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant
to Rule 13a-16 or 15d-16 of</FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=center><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
Securities Exchange Act of 1934</FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=center><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>For
the month of April 2005</STRONG></FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=center><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>Commission
File Number 000-5112</STRONG></FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2</FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=center><FONT
style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><STRONG>pSivida
Limited</STRONG></FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=center><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Translation
of registrant&#8217;s name into English) </FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=center><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Level 12
BGC Centre</FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=center><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">28 The
Esplanade</FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=center><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Perth WA
6000</FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=center><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Address
of principal executive offices)</FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Indicate
by check mark whether the registrant files or will file annual reports under
cover Form&nbsp;20-F or Form&nbsp;40-F). </FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=center><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Form 20-F
</FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Wingdings">&#253;</FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form
40-F </FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Wingdings">o</FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted
by Regulation S-T Rule 101(b)(1):</FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted
by Regulation S-T Rule 101(b)(7):</FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Indicate
by check mark whether the registrant by furnishing the information contained in
this Form is also thereby furnishing the information to the Commission pursuant
to Rule&nbsp;12g3-2(b) under the Securities Exchange Act of 1934.</FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=center><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Yes
</FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Wingdings">o</FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
</FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Wingdings">&#253;</FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If "Yes"
is marked, indicate below the file number assigned to the registrant in
connection with Rule&nbsp;12g3-2(b): 82- ___. </FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=center><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>SIGNATURE
</STRONG></FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant,
pSivida Limited, has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized. </FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Date:
April 4, 2005</FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify>
<TABLE cellSpacing=0 cellPadding=0 width="100%" align=center bgColor=#ffffff
border=0>
  <TR vAlign=top bgColor=#ffffff>
    <TD width="50%"><FONT face="Times New Roman" size=2>&nbsp;</FONT></TD>
    <TD width="1%"><FONT face="Times New Roman" size=2>&nbsp;</FONT></TD>
    <TD width="49%"><FONT face="Times New Roman" size=2>&nbsp;</FONT></TD></TR>
  <TR vAlign=top bgColor=#ffffff>
    <TD><FONT face="Times New Roman" size=2>&nbsp;</FONT></TD>
    <TD colSpan=2><FONT face="Times New Roman" size=2>pSivida
  Limited</FONT></TD></TR>
  <TR vAlign=top bgColor=#ffffff>
    <TD><FONT face="Times New Roman" size=2>&nbsp;<BR>&nbsp;</FONT></TD>
    <TD><FONT face="Times New Roman" size=2>&nbsp;<BR>&nbsp;</FONT></TD>
    <TD><FONT face="Times New Roman" size=2>&nbsp;<BR>&nbsp;</FONT></TD></TR>
  <TR vAlign=top bgColor=#ffffff>
    <TD><FONT face="Times New Roman" size=2></FONT></TD>
    <TD><FONT face="Times New Roman" size=2>By:&nbsp;&nbsp;</FONT></TD>
    <TD><FONT face="Times New Roman" size=2><FONT
      style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">/s/
      Aaron Finlay</FONT></FONT></TD></TR>
  <TR vAlign=top bgColor=#ffffff>
    <TD colSpan=2><FONT face="Times New Roman" size=1>&nbsp;</FONT></TD>
    <TD align=left>
      <HR align=left width="80%" color=#000000 noShade SIZE=2>
      <FONT size=2>Aaron Finlay</FONT></TD></TR>
  <TR vAlign=top bgColor=#ffffff>
    <TD colSpan=2><FONT face="Times New Roman" size=2>&nbsp;</FONT></TD>
    <TD><FONT face="Times New Roman" size=2><EM>Chief Financial Officer and
      Company Secretary</EM>&nbsp;</FONT></TD></TR></TABLE></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify>&nbsp;</DIV><FONT size=2></FONT><BR>
<DIV id=PGBRK style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=FTR>
<DIV style="WIDTH: 100%" align=left>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=center><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></FONT>&nbsp;</DIV></DIV>
<DIV id=GLFTR style="WIDTH: 100%" align=left><FONT
style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman"></FONT></DIV></DIV>
<DIV id=PN style="PAGE-BREAK-AFTER: always">
<DIV style="WIDTH: 100%; TEXT-ALIGN: center"><FONT
style="DISPLAY: inline; FONT-SIZE: 8pt" face="Times New Roman"></FONT></DIV>
<DIV style="WIDTH: 100%; TEXT-ALIGN: center">
<HR color=#000000 noShade SIZE=2>
</DIV></DIV>
<DIV id=HDR>
<DIV id=GLHDR style="WIDTH: 100%" align=right><FONT
style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman"></FONT></DIV></DIV></DIV><BR>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=center><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG><EM><U>EXHIBIT
INDEX</U></EM></STRONG></FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify>&nbsp;</DIV>
<DIV>
<TABLE cellSpacing=0 cellPadding=0 width="100%">
  <TR>
    <TD vAlign=top align=left width="15%">
      <DIV
      style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
      align=left><FONT
      style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>EXHIBIT
      99.1:</STRONG></FONT></DIV></TD>
    <TD vAlign=top align=left width="62%">
      <DIV
      style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
      align=left><FONT
      style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Webcast
      of pSivida Presentation Stephens Inc Nanotechnology Investors
      Conference</FONT></DIV></TD></TR>
  <TR>
    <TD vAlign=top align=left width="15%">&nbsp;</TD>
    <TD vAlign=top align=left width="62%">&nbsp;</TD></TR></TABLE></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><BR></DIV>
<DIV></DIV>
<DIV id=PGBRK style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=FTR>
<DIV id=GLFTR style="WIDTH: 100%" align=left><FONT
style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman"></FONT></DIV></DIV>
<DIV id=PN>
<DIV style="WIDTH: 100%; TEXT-ALIGN: center"><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">- 2
-</FONT></DIV>
<DIV style="WIDTH: 100%; TEXT-ALIGN: center">
<HR color=#000000 noShade SIZE=2>
</DIV></DIV>
<DIV id=HDR>
<DIV id=GLHDR style="WIDTH: 100%" align=right><FONT
style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman"></FONT></DIV></DIV></DIV></DIV></BODY></HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>v015750_ex99-1.htm
<TEXT>
<HTML><HEAD>
<TITLE>
</TITLE>
</HEAD><BODY id=38 bgColor=#ffffff>
<DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=right>
<IMG SRC="logo.jpg">
</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><BR></DIV>
<DIV align=left>
<TABLE cellSpacing=0 cellPadding=0 width="100%" border=0>
  <TR>
    <TD style="BORDER-BOTTOM: medium none" vAlign=top align=middle
      width="50%"><DIV
      style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
      align=left><FONT
      style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>ASX/MEDIA
      RELEASE</STRONG></FONT></DIV></TD>
    <TD style="BORDER-BOTTOM: medium none" vAlign=top align=middle
      width="50%"><DIV
      style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
      align=right><FONT
      style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>4</STRONG></FONT><FONT
      style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><SUP><STRONG>th</STRONG></SUP></FONT><FONT
      style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>
      April 2005</STRONG></FONT></DIV></TD></TR></TABLE></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><BR></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=center><BR></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=center><FONT
style="DISPLAY: inline; FONT-SIZE: 18pt; FONT-FAMILY: Times New Roman"><STRONG>Webcast
of pSivida Presentation </STRONG></FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=center><FONT
style="DISPLAY: inline; FONT-SIZE: 18pt; FONT-FAMILY: Times New Roman"><STRONG>Stephens
Inc Nanotechnology Investors Conference
<DIV>
<HR align=left width="100%" color=#000000 noShade SIZE=1>
</STRONG></FONT></DIV></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></FONT>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Global
nanotechnology company pSivida Limited (</FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>ASX:PSD,
NASDAQ:PSDV, Xetra:PSI</STRONG></FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">), is
pleased to announce that its Managing Director Mr Gavin Rezos will be presenting
at the Stephens Inc Nanotechnology Investors Conference on </FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>Tuesday
5</STRONG></FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><SUP><STRONG>th</STRONG></SUP></FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>
April </STRONG></FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">at</FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>
9.00am</STRONG></FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">. The
conference will be held at The Ritz-Carlton, Pasadena, California.</FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><BR></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A link to
the live web cast and recording of pSivida&#8217;s presentation will be available on
pSivida&#8217;s website </FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: blue; FONT-FAMILY: Times New Roman"><U>http://www.psivida.com/News/Presentations.asp</U>.</FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><BR></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">For
further details on the conference visit </FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: blue; FONT-FAMILY: Times New Roman"><U>www.stephens.com</U></FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: blue; FONT-FAMILY: Times New Roman"></FONT>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=center><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>-ENDS-</STRONG></FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><BR></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>Released
by:</STRONG></FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><BR></DIV>
<DIV align=left>
<TABLE cellSpacing=0 cellPadding=0 width="100%" border=0>
  <TR>
    <TD style="BORDER-BOTTOM: medium none" vAlign=top align=left width="50%">
      <DIV
      style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
      align=left><FONT
      style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>In
      Australia:</STRONG></FONT></DIV></TD>
    <TD style="BORDER-BOTTOM: medium none" vAlign=top align=left width="50%">
      <DIV
      style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
      align=left><FONT
      style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>In
      US:</STRONG></FONT></DIV></TD></TR>
  <TR>
    <TD style="BORDER-BOTTOM: medium none" vAlign=top align=left width="50%">
      <DIV
      style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
      align=left><FONT
      style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Josh
      Mann, CFA</FONT></DIV></TD>
    <TD style="BORDER-BOTTOM: medium none" vAlign=top align=left width="50%">
      <DIV
      style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
      align=left><FONT
      style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Beverly
      Jedynak</FONT></DIV></TD></TR>
  <TR>
    <TD style="BORDER-BOTTOM: medium none" vAlign=top align=left width="50%">
      <DIV
      style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
      align=left><FONT
      style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Investor
      Relations</FONT></DIV></TD>
    <TD style="BORDER-BOTTOM: medium none" vAlign=top align=left width="50%">
      <DIV
      style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
      align=left><FONT
      style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">President</FONT></DIV></TD></TR>
  <TR>
    <TD style="BORDER-BOTTOM: medium none" vAlign=top align=left width="50%">
      <DIV
      style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
      align=left><FONT
      style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">pSivida
      Limited</FONT></DIV></TD>
    <TD style="BORDER-BOTTOM: medium none" vAlign=top align=left width="50%">
      <DIV
      style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
      align=left><FONT
      style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Martin
      E. Janis &amp; Company, Inc.</FONT></DIV></TD></TR>
  <TR>
    <TD style="BORDER-BOTTOM: medium none" vAlign=top align=left width="50%">
      <DIV
      style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
      align=left><FONT
      style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Tel:
      + 61 8 9226 5099</FONT></DIV></TD>
    <TD style="BORDER-BOTTOM: medium none" vAlign=top align=left width="50%">
      <DIV
      style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
      align=left><FONT
      style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Tel:
      312-943-1100 ext. 12</FONT></DIV></TD></TR>
  <TR>
    <TD style="BORDER-BOTTOM: medium none" vAlign=top align=left width="50%">
      <DIV
      style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
      align=left><FONT
      style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: blue; FONT-FAMILY: Times New Roman">joshuamann@psivida.com</FONT></DIV></TD>
    <TD style="BORDER-BOTTOM: medium none" vAlign=top align=left width="50%">
      <DIV
      style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
      align=left><FONT
      style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: blue; FONT-FAMILY: Times New Roman">bjedynak@janispr.com</FONT></DIV></TD></TR></TABLE></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><BR></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><BR></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>Ticker
Symbols</STRONG></FONT></DIV>
<DIV align=left>
<TABLE cellSpacing=0 cellPadding=0 width="100%" border=0>
  <TR>
    <TD style="BORDER-BOTTOM: medium none" vAlign=top align=left width="40%">
      <DIV
      style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
      align=left><FONT
      style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Australian
      Stock Exchange</FONT></DIV></TD>
    <TD style="BORDER-BOTTOM: medium none" vAlign=top align=left width="60%">
      <DIV
      style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
      align=left><FONT
      style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">:
      PSD</FONT></DIV></TD></TR>
  <TR>
    <TD style="BORDER-BOTTOM: medium none" vAlign=top align=left width="40%">
      <DIV
      style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
      align=left><FONT
      style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NASDAQ</FONT></DIV></TD>
    <TD style="BORDER-BOTTOM: medium none" vAlign=top align=left width="60%">
      <DIV
      style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
      align=left><FONT
      style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">:
      PSDV</FONT></DIV></TD></TR>
  <TR>
    <TD style="BORDER-BOTTOM: medium none" vAlign=top align=left width="40%">
      <DIV
      style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
      align=left><FONT
      style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Frankfurt
      Stock Exchange (Xetra)</FONT></DIV></TD>
    <TD style="BORDER-BOTTOM: medium none" vAlign=top align=left width="60%">
      <DIV
      style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
      align=left><FONT
      style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">:
      PSI</FONT></DIV></TD></TR></TABLE></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><BR></DIV><BR>
<DIV id=PGBRK style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=FTR>
<DIV id=GLFTR style="WIDTH: 100%" align=left><FONT
style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman"></FONT></DIV></DIV>
<DIV id=PN style="PAGE-BREAK-AFTER: always">
<DIV style="WIDTH: 100%; TEXT-ALIGN: center"><FONT
style="DISPLAY: inline; FONT-SIZE: 8pt" face="Times New Roman"></FONT></DIV>
<DIV style="WIDTH: 100%; TEXT-ALIGN: center">
<HR color=#000000 noShade SIZE=2>
</DIV></DIV>
<DIV id=HDR>
<DIV id=GLHDR style="WIDTH: 100%" align=right><FONT
style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman"></FONT></DIV></DIV></DIV><BR>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>NOTES
TO EDITORS:</STRONG></FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><BR></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>pSivida
Limited</STRONG></FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">pSivida
is a global nanotechnology company committed to the biomedical sector and the
development of products in healthcare. The company&#8217;s focus is the development
and commercialisation of a modified form of silicon (porosified or
nano-structured silicon) known as BioSilicon&#8482;. As a new and exciting
biocompatible and biodegradable material, BioSilicon offers multiple potential
applications across the high growth healthcare sector, including controlled
release drug delivery, targeted cancer therapies (including brachytherapy and
localized chemotherapy), tissue engineering and orthopedics. Potential
diagnostics applications are being developed through its subsidiary AION
Diagnostics Limited. </FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><BR></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">pSivida
owns the intellectual property rights to BioSilicon, royalty free for use in or
on humans and animals. The IP portfolio consists of 24 patent families, 26
granted patents and over 80 patent applications. The core patent, which
recognises BioSilicon as a biomaterial was granted in the UK in 2000 and in the
US in 2001. </FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><BR></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">pSivida
is listed on NASDAQ (</FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>PSDV</STRONG></FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">), the
Australian Stock Exchange (</FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>PSD</STRONG></FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">) and in
Germany on the Frankfurt Stock Exchange on the XETRA system (</FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>German</STRONG></FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>Symbol:
PSI. Securities Code (WKN) 358705</STRONG></FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">).
pSivida&#8217;s shares also trade in the United Kingdom on the OFEX International
Market Service (IMS) under the ticker symbol </FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>PSD</STRONG></FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.</FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><BR></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
Company&#8217;s strategic partner and largest shareholder is the QinetiQ group, the
largest science and technology company in Europe. QinetiQ is the former UK
government Defence Evaluation Research Agency and was instrumental in
discovering BioSilicon. pSivida enjoys a strong relationship with QinetiQ having
access to its cutting edge research and development facilities. For more
information on QinetiQ visit </FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: blue; FONT-FAMILY: Times New Roman"><U>www.qinetiq.com</U>.</FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: blue; FONT-FAMILY: Times New Roman"></FONT>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">For more
information visit </FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: blue; FONT-FAMILY: Times New Roman"><U>www.psivida.com</U></FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><BR></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><BR></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><BR></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This
document contains forward-looking statements that involve risks and
uncertainties. Although we believe that the expectations reflected in such
forward-looking statements are reasonable at this time, we can give no assurance
that such expectations will prove to be correct. Given these uncertainties,
readers are cautioned not to place undue reliance on such forward-looking
statements. Actual results could differ materially from those anticipated in
these forward-looking statements due to many important factors including: our
failure to develop applications for BioSilicon due to regulatory, scientific or
other issues. Other reasons are contained in cautionary statements in the
Registration Statement on Form 20-F filed with the U.S. Securities and Exchange
Commission, including, without limitation, under Item&nbsp;3.D, "Risk Factors"
therein. We do not undertake to update any oral or written forward-looking
statements that may be made by or on behalf of pSivida.</FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><BR></DIV>
<DIV></DIV>
<DIV id=PGBRK style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=FTR>
<DIV id=GLFTR style="WIDTH: 100%" align=left><FONT
style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman"></FONT></DIV></DIV>
<DIV id=PN>
<DIV style="WIDTH: 100%; TEXT-ALIGN: center"><FONT
style="DISPLAY: inline; FONT-SIZE: 8pt" face="Times New Roman"></FONT></DIV>
<DIV style="WIDTH: 100%; TEXT-ALIGN: center">
<HR color=#000000 noShade SIZE=2>
</DIV></DIV>
<DIV id=HDR>
<DIV id=GLHDR style="WIDTH: 100%" align=right><FONT
style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman"></FONT></DIV></DIV></DIV></DIV></BODY></HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo.jpg
M_]C_X``02D9)1@`!`@$`2`!(``#_X0VO17AI9@``34T`*@````@`!P$2``,`
M```!``$```$:``4````!````8@$;``4````!````:@$H``,````!``(```$Q
M``(````;````<@$R``(````4````C8=I``0````!````I````-````!(````
M`0```$@````!061O8F4@4&AO=&]S:&]P($-3(%=I;F1O=W,`,C`P-3HP-#HP
M,R`R,SHS-SHS.0```````Z`!``,````!``$``*`"``0````!````M*`#``0`
M```!````.0`````````&`0,``P````$`!@```1H`!0````$```$>`1L`!0``
M``$```$F`2@``P````$``@```@$`!`````$```$N`@(`!`````$```QY````
M`````$@````!````2`````'_V/_@`!!*1DE&``$"`0!(`$@``/_M``Q!9&]B
M95]#30`!_^X`#D%D;V)E`&2``````?_;`(0`#`@("`D(#`D)#!$+"@L1%0\,
M#`\5&!,3%1,3&!$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`$-"PL-#@T0#@X0%`X.#A04#@X.#A01#`P,#`P1$0P,#`P,#!$,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,_\``$0@`,P"@`P$B``(1`0,1`?_=``0`
M"O_$`3\```$%`0$!`0$!``````````,``0($!08'"`D*"P$``04!`0$!`0$`
M`````````0`"`P0%!@<("0H+$``!!`$#`@0"!0<&"`4###,!``(1`P0A$C$%
M05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D
M1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F
M]C='5V=WAY>GM\?7Y_<1``("`0($!`,$!08'!P8%-0$``A$#(3$2!$%187$B
M$P4R@9$4H;%"(\%2T?`S)&+A<H*20U,58W,T\24&%J*R@P<F-<+21)-4HQ=D
M154V=&7B\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9VAI:FML;6YO8G-T=7
M9W>'EZ>WQ__:``P#`0`"$0,1`#\`]5225;,MS*@'T-8]@'N:0XN)_-#/3#DS
M)D&.)F02!OPCB*@+;*2JTYCLC%-V/7-@.TU..V'`^]I="I.ZW<VTTG&'J!VS
M;O\`SIC]U09.?Y?'&$IS/#D`,)"$Y1E?C&/S?U%PB3]'1R\S%P<9^5F6LHQZ
MA+[;"&M`^)6,SJ/7>M:])K'3>GGZ/4,MA==8.S\/`=LV5_NW9G_L,B9'2\1V
M2>L]6:^^Z@C[-C6/%E-3AH'XU`977Z[W?X:WU;6?Z16?VAF5T/R;:01&VK&:
M'"YUI_FZ1Z@8SW?Z3^;9_.?S==BD^\8^..,69S'%P\)!C']Z?%\BPQD023PQ
M'X_5S\!W5,7ZSGIK\^WJ&,<,Y&1Z[:P:K#8*J/3?CUT[6WM;?^A=_HET2S>C
M=+LPJ[LC+<VWJ6<_ULVY@.W=&RJBG=[_`+-BU?H:-W_&_P`Y;8M)3(@"!JI)
M)5LSJ%&&!ZDN>[Z+&ZF/%,R988H&>20A".\I+@"=`V4E0Q>LXV18*R'5N=HW
M=$$_N[FH^=E'$H]4,]0R!MF.?DY1QYO!+%+-&8ECA\THZ\-?U?F3PFZIL)(6
M+<;\=EQ;L+Q.WP15+"0E$2CK&0$AY20I)9GUCZP_HO2K,^NC[2ZMS&^D"6SO
M<&?2:RSZ,_NJ?0>J/ZOTG'ZB^G[.Z\.)I))V[7.K^DYM?[F[Z"<MXQQ</Z5<
M7T=!)5\_,KP<'(S;6N=7C5OM>UL;B&`O<&S'N]JJ=`Z]B]>PG9F+7956RQU1
M;:`'2T-=/L<_V^])/$+$;U.M.FDDDDE__]#U5`S@#BOF(T)F".1^_P"U'6;U
M[K%/2L/<6.R,K)=Z.'B5F'W6N^A4QW^#;^?;=_@:_P!(F9(<<)P_>B8_XRK`
MU/1S3U*_IV-D?8\=V9EWW-IP\=GT38YKG;KGM]M.-6QF^VW]Q1?O_:/Z2#9Z
MK-^WC=+/4VS^9O\`H*^,7JE-HR:&,#WM'J5E[G:Q]&Q]I]_I_1]1CEFV.N.:
M7.:!?ZH)9VWR/;_G+G.=,L>#!@G"<98LTO7P^C)$RE*/MR_PF6(N1D#H1MV=
M?KA_04L[.M$CX`JQT]K/0W`-C<X@@-`\/\'[53.)U/*R&6Y(K8VOZ+9=[?Y3
M?2<';_\`KBU&,#&AK9@<223_`)SI<M;EH3R<UEYDPEC@0(0CD'!,\/Z7"ME0
MB!NR7'=1^N'6L;ZTW]$Q,2K+:&M;C5B6V.L=4R^;;G6>DRFO<]]OZ+^:78KS
M_P#_`#L_Z_\`<-:(Z^36SRD!#A-<4XQ/D6[T+ZV=</UC/0NO44UVV;MGH@C8
M\,^T,;N]2UMM5E/T'_36MU::^I,MM;OJ(:0.Q#3[V+F^J?\`Y4,/_K7_`)ZN
M7;Y%N!=9]BN+7O<?YLS(,;OI?F>U4_B.`9L(AQQQRXHRQ\?R2R#Y8'^\NY:<
MKF"3+AD8WUX6N[$P.I%M]3]NW1X9`=_)W_N[58ZCE68N-ZM8!=N`]TD:_P!4
MM63F8UG2\AEU#R6NG;/.GTJW_O-<K_67!_3@X<.<TCYJC'.8X><O&.7YO'$2
MRG'\L_3^KR0;%:QUN)V:'UAZWU/IWU=;U7#92^UKF>LVT.+`QY].6ACV.W>H
MZO\`/0,SZVW5?4VGKU3:_M=XK8VMP<:_5+_3O;M#VV;&[+MGZ1:-^!^T?JU;
M@P"[(QW,9/`>0?2=_9LVKRX9UN=]7L#H-1)O.:XM9X"T-KH_\'ON6MRQ,\&*
M4M9&$)2/G%I<QDECF:.DHD1']>^CWV1]9.KX_P!3*NNV5T#-MV.%9:_TMEEF
MROV^IZG\RYK_`.<5SIGUALM^J8Z]G,8'MJMMLKJEK3Z;K&L8SU#8[W[&JG]>
MJ*\;ZGOQZA%5)HK8/!K7UL;_`-$+/I__`"5N_P")?_Y_<I:%?51G..0QN^'%
MQ?X8ZM)OUG^M?5>B=3R;L&J_I;ZK:+'TG8^DED&QHL>]V331O_3^Q:?^+K(I
MQ?JMEY-[ME-&1=98[P:RNI[W?YK4#ZN__DXZC_Q>9_U+D;_%YD8^+]5<O)RG
M!F/3D7/M<1(#6LJ<_P!OYR1V*S&3QXY2E9,)'5H-^NWUNZE5D]1Z3A4CIN(2
M;"X;W!H&_P#2.]:KU+&U^^UF.S]$NI^JGUA_;_3/M3ZQ3D5/-5[&F6[@`[?7
M/N]-['?G+F;.N?63ZQXF;9TFJOIG1:&6>K:]H=;8`PE]7YS&V/9]/TF_H?\`
MN0K?^*W_`)*S(X^T#_SW6D1HG'.7NQ'$91D";D*CI^X__]'U*VVNFM]MK@RN
MMI<][C`#6C<YSC_)7/\`U>ILZOEN^M&:T@6@U](H>(-.*3_/[?S<G/\`YRQ_
M^@].KU/35GZT9&!]A_9>=D?8J^JMLQF91@-8\MW-:\NVM_2-W?G>]-E?6KZM
M],KKQV95=M@:&48F)^GL(`VLKKIQ]_\`TD6,D<6I`$?^D[:Y3)R-W5[J<5HO
MOKN!L$Q75)&S[5?[O3<__!X[-^3;_HU89_SDZZ9M#^@]+/YC2#G6C^4]NZOI
M['?\'ZF5_P`)6K=7U>91773C6MHII,U55LT!_P!(=SW.LN=]*R^W?;8J'Q'E
MSECCK'+*<<N,0C*..-_ZR4Y0]/\`<_\`&V2$B;KT@_I'?_!#JU-L:R+'[W\N
M<!M']EONVM_M*:%0RYC-MUOK/GZ>T-T\-K4578DD`F)B3^C*KC_B<45*7FW4
MZ<V__&5;5@7C%S"&FFXM#VAS<4/V6,/^#M:/2>O25S__`#3_`.RW_G)]K_\`
M07T_^!^R?SV__KG\VG`U?DPYX&8@!TG&1UKTN3T+ZL?6"SZSGKW7G5!]4E@K
M(.]VS[/7L8T?HJ:JB[Z7Z3>NDZETQ]]C<C'<&W")!,3'T7-</HO:M))0\S@Q
M\QC./(+CH17IE&4=I19,41C^6]39O6[<8=,ZAE6M=G/&QNAU!,>#0T!ON_>5
M[J6-9DXOI4QNW`P=!`5M)00^'X88\N.YR]\5ER3EQ99_X3(9FP>R#"J?3BU5
M/C<QL&-0N,P/J/GX_P!;OVB\5?LRO(MR*@''?[@Y]#/3V_X.ZS][_!+NDE;Q
MQ&.$81VB!$>46+)CC,@R_1/$'&^MW2LSJW0[<'#V&][ZW#>=K8:]KW>Z'>"#
MTKZOW-^J#>A9Y:RU]-M3W,]X:7NL<Q[?H;MF]CUOI)UJ..)D9'<QX/\`!?/>
MF_57ZZ8^#E]'-]./T^T6.>6$/=8XM+/2I<6[Z:<AVSUO4_,_FUJ]$^JF?3]4
M\[HN<YE5^6^QS'5N+VC<VOTR[VM_PE?O76I)65D>7A'N:!CJ?T9/GW3/JS]>
M*L"[HYR*</I[]Y<YI%CW;@9JI<`',JO?_.;_`*'_`(&MSZC=!ZCT3!R:,\5A
M]MPL9Z;MPC8UG[K?W5TJ21*88(Q(())B*%GH_P#_TNZ^M^W]BOW?L_;O;/[5
MG[/_`.!^_P!;_1[50^I.W;;M_8L1I^R-V[_K_J>]?/Z22P_-^C_W3]5)+Y52
M27OU4DOE5))3]5)+Y5224_522^54DE/U4DOE5))3]5)+Y5224_522^54DE/U
M4DOE5))3]5)+Y5224__9_^T2:E!H;W1O<VAO<"`S+C``.$))300E```````0
M`````````````````````#A"24T#[0``````$`!(`````0`!`$@````!``$X
M0DE-!"8```````X`````````````/X```#A"24T$#0``````!````'@X0DE-
M!!D```````0````>.$))30/S```````)```````````!`#A"24T$"@``````
M`0``.$))32<0```````*``$``````````CA"24T#]0``````2``O9F8``0!L
M9F8`!@```````0`O9F8``0"AF9H`!@```````0`R`````0!:````!@``````
M`0`U`````0`M````!@```````3A"24T#^```````<```________________
M_____________P/H`````/____________________________\#Z`````#_
M____________________________`^@`````________________________
M_____P/H```X0DE-!`````````(``3A"24T$`@``````!``````X0DE-!`@`
M`````!`````!```"0````D``````.$))300>```````$`````#A"24T$&@``
M```#20````8``````````````#D```"T````"@!5`&X`=`!I`'0`;`!E`&0`
M+0`Q`````0`````````````````````````!``````````````"T````.0``
M```````````````````!`````````````````````````!`````!````````
M;G5L;`````(````&8F]U;F1S3V)J8P````$```````!28W0Q````!`````!4
M;W`@;&]N9P``````````3&5F=&QO;F<``````````$)T;VUL;VYG````.0``
M``!29VAT;&]N9P```+0````&<VQI8V5S5FQ,<P````%/8FIC`````0``````
M!7-L:6-E````$@````=S;&EC94E$;&]N9P`````````'9W)O=7!)1&QO;F<`
M````````!F]R:6=I;F5N=6T````,15-L:6-E3W)I9VEN````#6%U=&]'96YE
M<F%T960`````5'EP965N=6T````*15-L:6-E5'EP90````!);6<@````!F)O
M=6YD<T]B:F,````!````````4F-T,0````0`````5&]P(&QO;F<`````````
M`$QE9G1L;VYG``````````!"=&]M;&]N9P```#D`````4F=H=&QO;F<```"T
M`````W5R;%1%6%0````!````````;G5L;%1%6%0````!````````37-G951%
M6%0````!```````&86QT5&%G5$585`````$```````YC96QL5&5X=$ES2%1-
M3&)O;VP!````"&-E;&Q497AT5$585`````$```````EH;W)Z06QI9VYE;G5M
M````#T53;&EC94AO<GI!;&EG;@````=D969A=6QT````"79E<G1!;&EG;F5N
M=6T````/15-L:6-E5F5R=$%L:6=N````!V1E9F%U;'0````+8F=#;VQO<E1Y
M<&5E;G5M````$453;&EC94)'0V]L;W)4>7!E`````$YO;F4````)=&]P3W5T
M<V5T;&]N9P`````````*;&5F=$]U='-E=&QO;F<`````````#&)O='1O;4]U
M='-E=&QO;F<`````````"W)I9VAT3W5T<V5T;&]N9P``````.$))300H````
M```,`````3_P````````.$))3004```````$`````CA"24T$#``````,E0``
M``$```"@````,P```>```%^@```,>0`8``'_V/_@`!!*1DE&``$"`0!(`$@`
M`/_M``Q!9&]B95]#30`!_^X`#D%D;V)E`&2``````?_;`(0`#`@("`D(#`D)
M#!$+"@L1%0\,#`\5&!,3%1,3&!$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`$-"PL-#@T0#@X0%`X.#A04#@X.#A01#`P,#`P1$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,_\``$0@`,P"@`P$B``(1
M`0,1`?_=``0`"O_$`3\```$%`0$!`0$!``````````,``0($!08'"`D*"P$`
M`04!`0$!`0$``````````0`"`P0%!@<("0H+$``!!`$#`@0"!0<&"`4###,!
M``(1`P0A$C$%05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U
M%J*R@R9$DU1D1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?56
M9G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1``("`0($!`,$!08'!P8%-0$``A$#
M(3$2!$%187$B$P4R@9$4H;%"(\%2T?`S)&+A<H*20U,58W,T\24&%J*R@P<F
M-<+21)-4HQ=D154V=&7B\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9VAI:F
MML;6YO8G-T=79W>'EZ>WQ__:``P#`0`"$0,1`#\`]5225;,MS*@'T-8]@'N:
M0XN)_-#/3#DS)D&.)F02!OPCB*@+;*2JTYCLC%-V/7-@.TU..V'`^]I="I.Z
MW<VTTG&'J!VS;O\`SIC]U09.?Y?'&$IS/#D`,)"$Y1E?C&/S?U%PB3]'1R\S
M%P<9^5F6LHQZA+[;"&M`^)6,SJ/7>M:])K'3>GGZ/4,MA==8.S\/`=LV5_NW
M9G_L,B9'2\1V2>L]6:^^Z@C[-C6/%E-3AH'XU`977Z[W?X:WU;6?Z16?VAF5
MT/R;:01&VK&:'"YUI_FZ1Z@8SW?Z3^;9_.?S==BD^\8^..,69S'%P\)!C']Z
M?%\BPQD023PQ'X_5S\!W5,7ZSGIK\^WJ&,<,Y&1Z[:P:K#8*J/3?CUT[6WM;
M?^A=_HET2S>C=+LPJ[LC+<VWJ6<_ULVY@.W=&RJBG=[_`+-BU?H:-W_&_P`Y
M;8M)3(@"!JI))5LSJ%&&!ZDN>[Z+&ZF/%,R988H&>20A".\I+@"=`V4E0Q>L
MXV18*R'5N=HW=$$_N[FH^=E'$H]4,]0R!MF.?DY1QYO!+%+-&8ECA\THZ\-?
MU?F3PFZIL)(6+<;\=EQ;L+Q.WP15+"0E$2CK&0$AY20I)9GUCZP_HO2K,^NC
M[2ZMS&^D"6SO<&?2:RSZ,_NJ?0>J/ZOTG'ZB^G[.Z\.)I))V[7.K^DYM?[F[
MZ"<MXQQ</Z5<7T=!)5\_,KP<'(S;6N=7C5OM>UL;B&`O<&S'N]JJ=`Z]B]>P
MG9F+7956RQU1;:`'2T-=/L<_V^])/$+$;U.M.FDDDDE__]#U5`S@#BOF(T)F
M".1^_P"U'6;U[K%/2L/<6.R,K)=Z.'B5F'W6N^A4QW^#;^?;=_@:_P!(F9(<
M<)P_>B8_XRK`U/1S3U*_IV-D?8\=V9EWW-IP\=GT38YKG;KGM]M.-6QF^VW]
MQ1?O_:/Z2#9ZK-^WC=+/4VS^9O\`H*^,7JE-HR:&,#WM'J5E[G:Q]&Q]I]_I
M_1]1CEFV.N.:7.:!?ZH)9VWR/;_G+G.=,L>#!@G"<98LTO7P^C)$RE*/MR_P
MF6(N1D#H1MV=?KA_04L[.M$CX`JQT]K/0W`-C<X@@-`\/\'[53.)U/*R&6Y(
MK8VOZ+9=[?Y3?2<';_\`KBU&,#&AK9@<223_`)SI<M;EH3R<UEYDPEC@0(0C
MD'!,\/Z7"ME0B!NR7'=1^N'6L;ZTW]$Q,2K+:&M;C5B6V.L=4R^;;G6>DRFO
M<]]OZ+^:78KS_P#_`#L_Z_\`<-:(Z^36SRD!#A-<4XQ/D6[T+ZV=</UC/0NO
M44UVV;MGH@C8\,^T,;N]2UMM5E/T'_36MU::^I,MM;OJ(:0.Q#3[V+F^J?\`
MY4,/_K7_`)ZN7;Y%N!=9]BN+7O<?YLS(,;OI?F>U4_B.`9L(AQQQRXHRQ\?R
M2R#Y8'^\NY:<KF"3+AD8WUX6N[$P.I%M]3]NW1X9`=_)W_N[58ZCE68N-ZM8
M!=N`]TD:_P!4M63F8UG2\AEU#R6NG;/.GTJW_O-<K_67!_3@X<.<TCYJC'.8
MX><O&.7YO'$2RG'\L_3^KR0;%:QUN)V:'UAZWU/IWU=;U7#92^UKF>LVT.+`
MQY].6ACV.W>HZO\`/0,SZVW5?4VGKU3:_M=XK8VMP<:_5+_3O;M#VV;&[+MG
MZ1:-^!^T?JU;@P"[(QW,9/`>0?2=_9LVKRX9UN=]7L#H-1)O.:XM9X"T-KH_
M\'ON6MRQ,\&*4M9&$)2/G%I<QDECF:.DHD1']>^CWV1]9.KX_P!3*NNV5T#-
MMV.%9:_TMEEFROV^IZG\RYK_`.<5SIGUALM^J8Z]G,8'MJMMLKJEK3Z;K&L8
MSU#8[W[&JG]>J*\;ZGOQZA%5)HK8/!K7UL;_`-$+/I__`"5N_P")?_Y_<I:%
M?51G..0QN^'%Q?X8ZM)OUG^M?5>B=3R;L&J_I;ZK:+'TG8^DED&QHL>]V331
MO_3^Q:?^+K(IQ?JMEY-[ME-&1=98[P:RNI[W?YK4#ZN__DXZC_Q>9_U+D;_%
MYD8^+]5<O)RG!F/3D7/M<1(#6LJ<_P!OYR1V*S&3QXY2E9,)'5H-^NWUNZE5
MD]1Z3A4CIN(2;"X;W!H&_P#2.]:KU+&U^^UF.S]$NI^JGUA_;_3/M3ZQ3D5/
M-5[&F6[@`[?7/N]-['?G+F;.N?63ZQXF;9TFJOIG1:&6>K:]H=;8`PE]7YS&
MV/9]/TF_H?\`N0K?^*W_`)*S(X^T#_SW6D1HG'.7NQ'$91D";D*CI^X__]'U
M*VVNFM]MK@RNMI<][C`#6C<YSC_)7/\`U>ILZOEN^M&:T@6@U](H>(-.*3_/
M[?S<G/\`YRQ_^@].KU/35GZT9&!]A_9>=D?8J^JMLQF91@-8\MW-:\NVM_2-
MW?G>]-E?6KZM],KKQV95=M@:&48F)^GL(`VLKKIQ]_\`TD6,D<6I`$?^D[:Y
M3)R-W5[J<5HOOKN!L$Q75)&S[5?[O3<__!X[-^3;_HU89_SDZZ9M#^@]+/YC
M2#G6C^4]NZOI['?\'ZF5_P`)6K=7U>91773C6MHII,U55LT!_P!(=SW.LN=]
M*R^W?;8J'Q'ESECCK'+*<<N,0C*..-_ZR4Y0]/\`<_\`&V2$B;KT@_I'?_!#
MJU-L:R+'[W\N<!M']EONVM_M*:%0RYC-MUOK/GZ>T-T\-K4578DD`F)B3^C*
MKC_B<45*7FW4Z<V__&5;5@7C%S"&FFXM#VAS<4/V6,/^#M:/2>O25S__`#3_
M`.RW_G)]K_\`07T_^!^R?SV__KG\VG`U?DPYX&8@!TG&1UKTN3T+ZL?6"SZS
MGKW7G5!]4E@K(.]VS[/7L8T?HJ:JB[Z7Z3>NDZETQ]]C<C'<&W")!,3'T7-<
M/HO:M))0\S@Q\QC./(+CH17IE&4=I19,41C^6]39O6[<8=,ZAE6M=G/&QNAU
M!,>#0T!ON_>5[J6-9DXOI4QNW`P=!`5M)00^'X88\N.YR]\5ER3EQ99_X3(9
MFP>R#"J?3BU5/C<QL&-0N,P/J/GX_P!;OVB\5?LRO(MR*@''?[@Y]#/3V_X.
MZS][_!+NDE;QQ&.$81VB!$>46+)CC,@R_1/$'&^MW2LSJW0[<'#V&][ZW#>=
MK8:]KW>Z'>"#TKZOW-^J#>A9Y:RU]-M3W,]X:7NL<Q[?H;MF]CUOI)UJ..)D
M9'<QX/\`!?/>F_57ZZ8^#E]'-]./T^T6.>6$/=8XM+/2I<6[Z:<AVSUO4_,_
MFUJ]$^JF?3]4\[HN<YE5^6^QS'5N+VC<VOTR[VM_PE?O76I)65D>7A'N:!CJ
M?T9/GW3/JS]>*L"[HYR*</I[]Y<YI%CW;@9JI<`',JO?_.;_`*'_`(&MSZC=
M!ZCT3!R:,\5A]MPL9Z;MPC8UG[K?W5TJ21*88(Q(())B*%GH_P#_TNZ^M^W]
MBOW?L_;O;/[5G[/_`.!^_P!;_1[50^I.W;;M_8L1I^R-V[_K_J>]?/Z22P_-
M^C_W3]5)+Y5227OU4DOE5))3]5)+Y5224_522^54DE/U4DOE5))3]5)+Y522
M4_522^54DE/U4DOE5))3]5)+Y5224__9`#A"24T$(0``````4P````$!````
M#P!!`&0`;P!B`&4`(`!0`&@`;P!T`&\`<P!H`&\`<````!(`00!D`&\`8@!E
M`"``4`!H`&\`=`!O`',`:`!O`'``(`!#`%,````!`#A"24T$!@``````!P`$
M`````0$`_^$7^6AT='`Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\`/#]X<&%C
M:V5T(&)E9VEN/2?ON[\G(&ED/2=7-4TP37!#96AI2'IR95-Z3E1C>FMC.60G
M/SX*/'@Z>&UP;65T82!X;6QN<SIX/2=A9&]B93IN<SIM971A+R<@>#IX;7!T
M:STG6$U0('1O;VQK:70@,RXP+3(X+"!F<F%M97=O<FL@,2XV)SX*/')D9CI2
M1$8@>&UL;G,Z<F1F/2=H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S`R+S(R+7)D
M9BUS>6YT87@M;G,C)R!X;6QN<SII6#TG:'1T<#HO+VYS+F%D;V)E+F-O;2]I
M6"\Q+C`O)SX*"B`\<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TG=75I9#IC
M-61E935A,BUA-&)A+3$Q9#DM.#8P-BTX-S,R8F,T,C$Y-V,G"B`@>&UL;G,Z
M97AI9CTG:'1T<#HO+VYS+F%D;V)E+F-O;2]E>&EF+S$N,"\G/@H@(#QE>&EF
M.D-O;&]R4W!A8V4^,3PO97AI9CI#;VQO<E-P86-E/@H@(#QE>&EF.E!I>&5L
M6$1I;65N<VEO;CXQ.#`\+V5X:68Z4&EX96Q81&EM96YS:6]N/@H@(#QE>&EF
M.E!I>&5L641I;65N<VEO;CXU-SPO97AI9CI0:7AE;%E$:6UE;G-I;VX^"B`\
M+W)D9CI$97-C<FEP=&EO;CX*"B`\<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U
M=#TG=75I9#IC-61E935A,BUA-&)A+3$Q9#DM.#8P-BTX-S,R8F,T,C$Y-V,G
M"B`@>&UL;G,Z<&1F/2=H='1P.B\O;G,N861O8F4N8V]M+W!D9B\Q+C,O)SX*
M(#PO<F1F.D1E<V-R:7!T:6]N/@H*(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B
M;W5T/2=U=6ED.F,U9&5E-6$R+6$T8F$M,3%D.2TX-C`V+3@W,S)B8S0R,3DW
M8R<*("!X;6QN<SIP:&]T;W-H;W`])VAT='`Z+R]N<RYA9&]B92YC;VTO<&AO
M=&]S:&]P+S$N,"\G/@H@(#QP:&]T;W-H;W`Z2&ES=&]R>3X\+W!H;W1O<VAO
M<#I(:7-T;W)Y/@H@/"]R9&8Z1&5S8W)I<'1I;VX^"@H@/')D9CI$97-C<FEP
M=&EO;B!R9&8Z86)O=70])W5U:60Z8S5D964U83(M831B82TQ,60Y+3@V,#8M
M.#<S,F)C-#(Q.3=C)PH@('AM;&YS.G1I9F8])VAT='`Z+R]N<RYA9&]B92YC
M;VTO=&EF9B\Q+C`O)SX*("`\=&EF9CI/<FEE;G1A=&EO;CXQ/"]T:69F.D]R
M:65N=&%T:6]N/@H@(#QT:69F.EA297-O;'5T:6]N/C<R+S$\+W1I9F8Z6%)E
M<V]L=71I;VX^"B`@/'1I9F8Z65)E<V]L=71I;VX^-S(O,3PO=&EF9CI94F5S
M;VQU=&EO;CX*("`\=&EF9CI297-O;'5T:6]N56YI=#XR/"]T:69F.E)E<V]L
M=71I;VY5;FET/@H@/"]R9&8Z1&5S8W)I<'1I;VX^"@H@/')D9CI$97-C<FEP
M=&EO;B!R9&8Z86)O=70])W5U:60Z8S5D964U83(M831B82TQ,60Y+3@V,#8M
M.#<S,F)C-#(Q.3=C)PH@('AM;&YS.GAA<#TG:'1T<#HO+VYS+F%D;V)E+F-O
M;2]X87`O,2XP+R<^"B`@/'AA<#I#<F5A=&5$871E/C(P,#4M,#0M,#-4,C,Z
M,S<Z,SDM,#4Z,#`\+WAA<#I#<F5A=&5$871E/@H@(#QX87`Z36]D:69Y1&%T
M93XR,#`U+3`T+3`S5#(S.C,W.C,Y+3`U.C`P/"]X87`Z36]D:69Y1&%T93X*
M("`\>&%P.DUE=&%D871A1&%T93XR,#`U+3`T+3`S5#(S.C,W.C,Y+3`U.C`P
M/"]X87`Z365T861A=&%$871E/@H@(#QX87`Z0W)E871O<E1O;VP^061O8F4@
M4&AO=&]S:&]P($-3(%=I;F1O=W,\+WAA<#I#<F5A=&]R5&]O;#X*(#PO<F1F
M.D1E<V-R:7!T:6]N/@H*(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2=U
M=6ED.F,U9&5E-6$R+6$T8F$M,3%D.2TX-C`V+3@W,S)B8S0R,3DW8R<*("!X
M;6QN<SIX87!-33TG:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O,2XP+VUM+R<^
M"B`@/'AA<$U-.D1O8W5M96YT240^861O8F4Z9&]C:60Z<&AO=&]S:&]P.F,U
M9&5E-6$Q+6$T8F$M,3%D.2TX-C`V+3@W,S)B8S0R,3DW8SPO>&%P34TZ1&]C
M=6UE;G1)1#X*(#PO<F1F.D1E<V-R:7!T:6]N/@H*(#QR9&8Z1&5S8W)I<'1I
M;VX@<F1F.F%B;W5T/2=U=6ED.F,U9&5E-6$R+6$T8F$M,3%D.2TX-C`V+3@W
M,S)B8S0R,3DW8R<*("!X;6QN<SID8STG:'1T<#HO+W!U<FPN;W)G+V1C+V5L
M96UE;G1S+S$N,2\G/@H@(#QD8SIF;W)M870^:6UA9V4O:G!E9SPO9&,Z9F]R
M;6%T/@H@/"]R9&8Z1&5S8W)I<'1I;VX^"@H\+W)D9CI21$8^"CPO>#IX;7!M
M971A/@H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`*/#]X<&%C:V5T(&5N9#TG=R<_/O_B#%A)0T-?4%)/1DE,10`!`0``
M#$A,:6YO`A```&UN=')21T(@6%E:(`?.``(`"0`&`#$``&%C<W!-4T94````
M`$E%0R!S4D="``````````````````#VU@`!`````-,M2%`@(```````````
M````````````````````````````````````````````````````$6-P<G0`
M``%0````,V1E<V,```&$````;'=T<'0```'P````%&)K<'0```($````%')8
M65H```(8````%&=865H```(L````%&)865H```)`````%&1M;F0```)4````
M<&1M9&0```+$````B'9U960```-,````AG9I97<```/4````)&QU;6D```/X
M````%&UE87,```0,````)'1E8V@```0P````#')44D,```0\```(#&=44D,`
M``0\```(#&)44D,```0\```(#'1E>'0`````0V]P>7)I9VAT("AC*2`Q.3DX
M($AE=VQE='0M4&%C:V%R9"!#;VUP86YY``!D97-C`````````!)S4D="($E%
M0S8Q.38V+3(N,0``````````````$G-21T(@245#-C$Y-C8M,BXQ````````
M``````````````````````````````````````````````````````````!8
M65H@````````\U$``0````$6S%A96B``````````````````````6%E:(```
M`````&^B```X]0```Y!865H@````````8ID``+>%```8VEA96B`````````D
MH```#X0``+;/9&5S8P`````````6245#(&AT='`Z+R]W=W<N:65C+F-H````
M```````````6245#(&AT='`Z+R]W=W<N:65C+F-H````````````````````
M`````````````````````````````````````````&1E<V,`````````+DE%
M0R`V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R('-P86-E("T@<U)'0@``
M````````````+DE%0R`V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R('-P
M86-E("T@<U)'0@````````````````````````````!D97-C`````````"Q2
M969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M,BXQ````
M```````````L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q
M.38V+3(N,0``````````````````````````````````=FEE=P``````$Z3^
M`!1?+@`0SQ0``^W,``03"P`#7)X````!6%E:(```````3`E6`%````!7'^=M
M96%S``````````$````````````````````````"CP````)S:6<@`````$-2
M5"!C=7)V````````!``````%``H`#P`4`!D`'@`C`"@`+0`R`#<`.P!``$4`
M2@!/`%0`60!>`&,`:`!M`'(`=P!\`($`A@"+`)``E0":`)\`I`"I`*X`L@"W
M`+P`P0#&`,L`T`#5`-L`X`#E`.L`\`#V`/L!`0$'`0T!$P$9`1\!)0$K`3(!
M.`$^`44!3`%2`5D!8`%G`6X!=0%\`8,!BP&2`9H!H0&I`;$!N0'!`<D!T0'9
M`>$!Z0'R`?H"`P(,`A0"'0(F`B\".`)!`DL"5`)=`F<"<0)Z`H0"C@*8`J("
MK`*V`L$"RP+5`N`"ZP+U`P`#"P,6`R$#+0,X`T,#3P-:`V8#<@-^`XH#E@.B
M`ZX#N@/'`],#X`/L`_D$!@03!"`$+00[!$@$501C!'$$?@2,!)H$J`2V!,0$
MTP3A!/`$_@4-!1P%*P4Z!4D%6`5G!7<%A@66!:8%M07%!=4%Y07V!@8&%@8G
M!C<&2`99!FH&>P:,!IT&KP;`!M$&XP;U!P<'&0<K!ST'3P=A!W0'A@>9!ZP'
MOP?2!^4'^`@+"!\(,@A&"%H(;@B"")8(J@B^"-((YPC["1`))0DZ"4\)9`EY
M"8\)I`FZ"<\)Y0G["A$*)PH]"E0*:@J!"I@*K@K%"MP*\PL+"R(+.0M1"VD+
M@`N8"[`+R`OA"_D,$@PJ#$,,7`QU#(X,IPS`#-D,\PT-#28-0`U:#70-C@VI
M#<,-W@WX#A,.+@Y)#F0.?PZ;#K8.T@[N#PD/)0]!#UX/>@^6#[,/SP_L$`D0
M)A!#$&$0?A";$+D0UQ#U$1,1,1%/$6T1C!&J$<D1Z!('$B8211)D$H02HQ+#
M$N,3`Q,C$T,38Q.#$Z03Q1/E%`84)Q1)%&H4BQ2M%,X4\!42%3055A5X%9L5
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M<C:N-NDW)#=@-YPWUS@4.%`XC#C(.04Y0CE_.;PY^3HV.G0ZLCKO.RT[:SNJ
M.^@\)SQE/*0\XSTB/6$]H3W@/B`^8#Z@/N`_(3]A/Z(_XD`C0&1`ID#G02E!
M:D&L0>Y",$)R0K5"]T,Z0WU#P$0#1$=$BD3.11)%546:1=Y&(D9G1JM&\$<U
M1WM'P$@%2$M(D4C721U)8TFI2?!*-TI]2L1+#$M32YI+XDPJ3'),NDT"34I-
MDTW<3B5.;DZW3P!/24^33]U0)U!Q4+M1!E%049M1YE(Q4GQ2QU,34U]3JE/V
M5$)4CU3;52A5=57"5@]67%:I5O=71%>25^!8+UA]6,M9&EEI6;A:!UI66J9:
M]5M%6Y5;Y5PU7(9<UETG77A=R5X:7FQ>O5\/7V%?LV`%8%=@JF#\84]AHF'U
M8DEBG&+P8T-CEV/K9$!DE&3I93UEDF7G9CUFDF;H9SUGDV?I:#]HEFCL:4-I
MFFGQ:DAJGVKW:T]KIVO_;%=LKVT(;6!MN6X2;FMNQ&\>;WAOT7`K<(9PX'$Z
M<95Q\')+<J9S`7-=<[AT%'1P=,QU*'6%=>%V/G:;=OAW5G>S>!%X;GC,>2IY
MB7GG>D9ZI7L$>V-[PGPA?(%\X7U!?:%^`7YB?L)_(W^$?^6`1X"H@0J!:X'-
M@C""DH+T@U>#NH0=A("$XX5'A:N&#H9RAM>'.X>?B`2(:8C.B3.)F8G^BF2*
MRHLPBY:+_(QCC,J-,8V8C?^.9H[.CS:/GI`&D&Z0UI$_D:B2$9)ZDN.339.V
ME""4BI3TE5^5R98TEI^7"I=UE^"83)BXF229D)G\FFB:U9M"FZ^<')R)G/>=
M9)W2GD">KI\=GXN?^J!IH-BA1Z&VHB:BEJ,&HW:CYJ16I,>E.*6IIAJFBZ;]
MIVZGX*A2J,2I-ZFIJARJCZL"JW6KZ:Q<K-"M1*VXKBVNH:\6KXNP`+!UL.JQ
M8+'6LDNRPK,XLZZT);2<M1.UBK8!MGFV\+=HM^"X6;C1N4JYPKH[NK6[+KNG
MO"&\F[T5O8^^"KZ$OO^_>K_UP'#`[,%GP>/"7\+;PUC#U,11Q,[%2\7(QD;&
MP\=!Q[_(/<B\R3K)N<HXRK?+-LNVS#7,M<TUS;7.-LZVSS?/N-`YT+K1/-&^
MTC_2P=-$T\;42=3+U4[5T=95UMC77-?@V&38Z-ELV?':=MK[VX#<!=R*W1#=
MEMX<WJ+?*=^OX#;@O>%$X<SB4^+;XV/CZ^1SY/SEA.8-YI;G'^>IZ#+HO.E&
MZ=#J6^KEZW#K^^R&[1'MG.XH[K3O0._,\%CPY?%R\?_RC/,9\Z?T-/3"]5#U
MWO9M]OOWBO@9^*CY./G'^E?ZY_MW_`?\F/TI_;K^2_[<_VW____N``Y!9&]B
M90!D``````'_VP"$``8$!`0%!`8%!08)!@4&"0L(!@8("PP*"@L*"@P0#`P,
M#`P,$`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P!!P<'#0P-&!`0&!0.
M#@X4%`X.#@X4$0P,#`P,$1$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#/_``!$(`#D`M`,!$0`"$0$#$0'_W0`$`!?_Q`&B````!P$!`0$!
M```````````$!0,"!@$`!P@)"@L!``("`P$!`0$!``````````$``@,$!08'
M"`D*"Q```@$#`P($`@8'`P0"!@)S`0(#$00`!2$2,4%1!A-A(G&!%#*1H0<5
ML4(CP5+1X3,68O`D<H+Q)4,T4Y*BLF-SPC5$)Y.CLS875&1TP]+B"":#"0H8
M&82414:DM%;352@:\N/SQ-3D]&5UA96EM<75Y?5F=H:6IK;&UN;V-T=79W>'
MEZ>WQ]?G]SA(6&AXB)BHN,C8Z/@I.4E9:7F)F:FYR=GI^2HZ2EIJ>HJ:JKK*
MVNKZ$0`"`@$"`P4%!`4&!`@#`VT!``(1`P0A$C%!!5$382(&<8&1,J&Q\!3!
MT>$C0A528G+Q,R0T0X(6DE,EHF.RP@=STC7B1(,75),("0H8&28V11HG9'15
M-_*CL\,H*=/C\X24I+3$U.3T976%E:6UQ=7E]4969G:&EJ:VQM;F]D=79W>'
MEZ>WQ]?G]SA(6&AXB)BHN,C8Z/@Y25EI>8F9J;G)V>GY*CI*6FIZBIJJNLK:
MZOK_V@`,`P$``A$#$0`_`/5.*NQ5V*NQ5V*I-YF\WZ#Y;M5GU2XX22GC:VD8
M,EQ._9(HE^-VP@6U9<\<8]3'XG_,SS&/61HO*&F-O$CQK>:BZ^+JQ]""O\M)
M77#L/-Q_WV3_`&J/^FR-?ESJOF276/,VBZM??I:WT6YA@M-3:-(G=I(_4DC<
M1@(3%5<9`+I9S,I1D>(0/U,ZR+FNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5
MV*O_T/5.*H;4+N:U@$D5L]R>5"B$`@4)Y;YAZW4SPPXHPEFW^F'^Z91%J.EZ
MS::B)%C#1SPFDL+TY+]U01E'9W:N+56(W&</KQS^J*9P,4)=^:]/M)6CGAN$
M()4$QT#<32JDG<9@ZGVDP8)&,XY8[_S/JX?YOJ9#"3R0MSYCDU*U>VT5Y+:]
ME(2.\EMO7CB+;<F0.G3W;):3VCP9YB,(996>'Z/3'B_G^KTL<N"?#L1$I9IO
MEO0?*UXNH7LDVN>:KP4DU*YXM.P_EC!/"WA[*D?_``V9O:7;&/3$1-SR3^C%
M#ZG'T^B`/$?5+^?)-=:\R7]MHX-I9-^F[US;:78R$'E*17U'*]((E_>2M_(O
M\S+F1H<\LT.*4)8?Z,DZB?`*CZI2^G\?T41Y0\LP>7-$CT])3<W+N]Q?WC_;
MGN9CREE;_6;I_*O%<RR;8X,(QQKK_%_2DG6!N=BJR::*&-I97$<:BK.QH!])
MRO+ECCB92(C&/\4D@6EZ>9M">01K=IR)H"0P'_!$4S50]H-%*7",D;_SHQ_T
MU<+/PI=R9@@@$&H/0YN`;:TMM_,%A/J;Z<@?ZPA922HXU3KO7-3@[;P9-0=/
M'B\2)D.7I_=_%L.,@6F6;=K=BK&?//YA:#Y+MK6XUA9VCO':.+ZN@D/)%Y&M
M67)1C;CZC51P@&75.](U.VU72K/4[4,+:]ACN(0XHW"10R\A4T-#@(;<<Q*(
MD.4D3)(D<;2.>*("S,>P`J3@9DI-Y=\Z^5O,CSIH>HQ7S6P5IQ'R^$/7C7D!
MUXG"00TXL\,GTFT[P-SL5=BK_]'U3BJV50T3J14%2"#3P]]LAD%Q(\DAA6DR
MK#YFM3&R\9D:-PAB(Z'_`'S11T&>>=FY1#M&'"162)A+A.'N/_*-Z/X8N5,7
M`J'F3S+I&M>M!ILWUC]%W)MKJ516/U2G(HC='*?MT^RV;+VU%8L?]:7W!HT>
M:,Y2`_A3CR'_`,<^Y_XS?\:C)^QG]Q/_`(9_O8MFHYA++Z59O,EZTI6D=(D#
MF$"@H.DU5/T9J-9D&3M#*9$>G]W'B.'_`+&?3_I6R(J`9FEG;K<?6>`,_`1*
MYZJG7BO\H)W;^;_8KGH\10IPJ%VK84L!N?SN\CV>N:EH][)<6L^E>J+F:6-1
M$6A(4K&0Q=V8GX%X?%D^`N">T,8D8G;A4O)WYY>3_-&MKH]M'<VEU-R^J-<J
M@28J">(*,_%Z"O%L3`A&#M''DEPBP4U\_7$H%I`"1$W)V'8L*`?=7.!]M,TA
MX</X#Q2_SMG<Z<<RM/E&RN-%CGL7,EVR*X8L.+D_:7P7`?9C#ET<9X3Q9C$2
M^KT3_G0_H_CB7QB)4>2>^7;+4++3EM[UE9D)]/B2:(?V2?8YTG8>DSZ?3C'F
M()B?1P^KAA_-:<L@380MG=Z`VO20P6S+J(:0/,1L2*\M^7?Y9A:74Z&6ME"$
M"-1Q3XI_TO\`*?Q?[UE(2X=SLE<OYJ>6X?.Z^39HKJ+5FD6)':-?0)>/U%(?
MGRHR]/@^UG3\)JW7'6P&3P]^)?YZ_-#RWY+FLX=66XDEO5=XDMD60A8R`2W)
MDI4M\.,8DIU.LAA($KW2S\U=;_+^RTO2[CSEI<M_;SNQLXE0,T;E`6Y#U$I\
M.W5L,0>C7K,F*,0<@ME6BZCHD?E2RU&T'U/1$LHYX%D''TK81!EY"K4X1^^1
M/-R<<X^&"-H</^Q>?Q?\Y">0M2N+G32;BSCECDCM[ZX15A=BI`KQ9G3EVYK_
M`*W')^&7!':F*1,=Q_28I_SBU_O=YA_XQ6O_`!*7)97$[&YR^#TCSQ^<GE#R
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M&`2S#B!MVP^SG:VGTFGGXDO5Q\48?Q2](9YL9D=F_+\4U_J$]VK@&>3U)E1V
M4HO(FA^`JWRYY+L7'/4YYY0?[R?'/AG.'AQXO^%RA/\`Y6+D/"*9IGH3B.Q5
M\V>6]/L;_P#YR-U""]@CN8!>WT@BE4.O-$9E;B=OA.XR\GTO/8H"6K((OU2_
M2U^9EI;:3^>VD2Z?$MOZLVG3LL8"KS,W!C04'Q*OQ8QWBC61$=5&MOI?0FM:
M-;ZI:^E(>$B'E%*-RI_B#FD[6[*QZW'P2],H_1/^;_QUZ7',Q+#V37_+<]0?
MW#'J/BA?YC]D_P##9P,HZ[LF=_Y,G^M@R?\`$R_TLG*].0,ST?58=3LEN8QQ
M:O&2/KQ8=1GH/97:4-9A&2.Q^F<?YDW%G#A-,7TG_E-KC_C)/_'.-[,_XV)_
MU\O^^<B?]V'F/Y^6\F@_F%Y=\UP`J']-G8=Y+*4,?OC=1GI./<4\MVF.#+&?
MX]"GY^X^;?SYT?1T/JV=I]51P-P8U!NY?O1N.,=HHU/[W51CT%?\6G/_`#E'
M_P`<70O^8F;_`)-C!B;NV?IC[T[\R320_P#..RO&:,=&LT)'\L@B1O\`A6P#
MZF[*:TG^9']"1?D5Y=T.]_+'6)[RRAN9+FXN(Y6E17)2.%."@D5'$EF%/VL.
M0[M'9N*)PR)%_P!B6?\`.+7^]WF'_C#:_P#$I<.5K[&YR^#)/,'E#\K?*/FB
M?S=YGU.2ZO;N26XCTVY$<P9Y#U2%4YL(_LIR^!<B)$B@Y.7!@Q3\29LG^&3S
M+2]9T35/SPTK4_+]HVG:;<W]N8K<HL1W4)(W!"542'DU!_-EA'IW=;#)&6I!
M@.&/$'U9F.]._P#_T_5.*L'_`#`\S:H;NU\G>6G`\R:NI9[GJ+&S&TER_P#E
M?LQ?Y?\`L<E$=2X>IRRL8X?7+_81_G)_Y;\I:+Y?T*#1;.`-;1?%(T@#-+*W
MVY9"?M.YZG*LV..05,"8[I>IR,&(8XU%)?.FFV%I#;/;0)"SNP<H*5`&<%[6
M:#!AA`XX1QF4I7PN?@D3=K?*-MI,L#_6XHY;AI>,*,.3%0H)HO\`*.[9/V3[
M/P9L,Y9(1R2C/^+^J&.HR&)`MF<4442!(D6-!T50`/N&=UCQ1@*B!&/]'TN.
M3:[)H=BKYBTWS#I7E_\`YR!U/4]5F^KV*7U[')-0L%,JLBEN-3QY'?+R+B\W
M#+&&K)ERXI+O.&L:?YN_/'2'T247=LL]C`DZ`\6]&3U9&6H'PH"V_P#DXQ%1
M7/D&74QX=_I>[><+W6+,0RVDQCM7'&3B!4/U%217XAG$^U&KU>GX98I<.*7I
MEP@?7_6_I?[UZS!&)Y\T+JGFO3KW1)("C&ZE4*8RNRM_-RZ;=LP^T/:33ZC1
MF%'Q9Q^BOIE_.XO]RRAA(EY(KR+;RQZ=-,X(2:2L=>X44)^_,SV.P2CIY2/+
M)+T_YO\`%^/YK'4'=+])_P"4VN/^,D_\<U?9G_&Q/^OE_P!\SG_=A(O^<B]#
M^O\`D`WR+672KF.<GOZ<G[E_^)JW^QST?&=W0]JX^+%?\TL$_P"<<M/N-5\Y
M:GK]XQE>QM5B$K?[\FHB_=%$RY/+L*<'LF)ED,S_``A/_P#G*/\`XXNA?\Q,
MW_)L9'$Y';/TQ]Z?Z[9S7G_./2PPJ6D&BVLO$=:0I'*W_"H<`^IOR1O2?YD6
M$_DW^8OE30OR^U73-5O!;WJSS200<69YA-$JJ(PH/)N:E:9*<22X?9^JA#$8
MR.Z__G%L$7_F$$4(BM01_LI<<J]C<Y?!C7E#5_+.J_FCJ>J_F%.O!&F>!+H$
MP^M')Q2)UH?@BCY<(S\/PY(@@;./@R0EG,LJM-Y@TC7_`,_-+U+1ZG3FO;.*
MW8IZ8(A18R57LE5^'_)QJHI.6,]4#'Z;B^H<QWI7_]3U%?7<5E8W%Y+7TK:)
MYI*=>,:EC3Z!BQE*@3W,)_*72KB;3;CSCJ@Y:UYG;ZTY._I6G_'M`A[(L=&_
MZYR<CT<310)!R2^K)_N?X6=RRQ0QM+*ZQQ("SNY"JH'4DG89!S":>;^9?-4/
MF8I;^7&62RM)&%WKTRDV:M2A2W&S7DW^3'^Z7]N7.?\`:'28)PA+43\/'C)E
MPQ_O,O\`0@UX=3*9(Q#B_P!L_P`G'_BTY\@KI%G!/&L@^MRR`-<7#*;B?84+
M'8=?LQ1CTX_V<QNP.U<$XRA$0T\1/APXK]?#_.E_JF2<G(E@,=]YR_BFS'.I
M8.Q5V*OF[RS9VE[_`,Y%:M:7<*7%M-<:BDT$BAD93&]0RG8Y>?I>>PQ!U9!Y
M7+]+VKR[^6?D?R[J+ZEI&EQV]ZP*B8M)(45NHC]1F"5_R<J,B7<8M)CQFXC=
MDLT,4T;12H)(W%&1A4$?+*<N*.2)C(<49?PR<H&DL7RKH*R<Q:@GK0LQ7[B:
M9J(^SFA$N+P_MEP_Z7B;/&EWIHJ*BA4`55%%4"@`]LW,8B(H"@&I"Q:1IT5X
MUY'`%N6+%I*FI+=>],PL?9FGAE.:,:RF_7O_`!_4R,R12[4],L-4T^?3]0A6
MXLKI#'/"U:,IZC:AS/:YP$A1Y(#RWY0\M^6H9H=#L4L8[A@\ZH6;DRB@)+EC
ML,))+#%@AC%1%.\R>3_+?F6&"'7+%+Z.V8O"KLZ\684)^!E[8@D+EP0R?4+3
M"ST^RL]/AT^VB6.RMXE@B@ZJ(U7B%^*M1QVWP6SC``4.3&M,_*C\O=+U8:K9
M:-#'>JW.-B7=(V_FCC=FC0^'%?A_9R1F7'AHL49<0CNF/ESR1Y5\MRW$NB:>
MEE)=A1<,C.W/B25KS9NG)L!D2V8M/#'](JTLU7\I/R\U759-5OM'CDO)FYS,
M'D19'/5G1&5&)_:^'XOVL(F6J>AQ2EQ&.Z+/Y<>1_P!+VVKKI$*:C:>E]6FC
MYIP]$`1\41@GP@?RX\19_E,?$)5N&29%R'__U?0GG_4]?TK1H=1T;3VU5K:Y
M1K[3TW>6U9'20(`&)92R/]EOLY*(<?4SE&-Q'%1]4?Z+%++\RO,]Y:Q6'E7R
M'?1F-%CB-_QL[6%5%`*GJJ_RKQR1B.I<6.KF14,<O\[TQ15O^7/F+S%,EW^8
M.K?78%(>/R_8<H;%2-QZIVDGI_E8.(#DS&EG/?*;_H1^AG2Z-I"PQ0+90K!`
MHC@B$:A40?LJM**/EF'GT6',;R0CD/\`3CQ.?`\(H;!M-(TN-U=+2%74@JP1
M001T(VRJ'9FFB1(8\8E'^A%EQGO1>9S%V*NQ5+H?+7EZ#4VU6'3+6/4W+,]Z
MD*+,2XHQ,@'+XOVM\-EK&&`EQ`#B[TQP-CL5=BKL5=BKL5=BKL5=BKL5=BKL
M5=BKL5?_UO5.*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
)5V*NQ5V*O__9
`
end
</TEXT>
</DOCUMENT>
</SUBMISSION>
